Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Episode 36 with Dr. Jenny Ting on the inflammasome
Teriflunomide for multiple sclerosis.
Episode 65 with Dr. Gisela Kobelt on the economics of long-term brain health in MS
Episode 40 with Dr. Raj Kapoor on a clinical trial of phenytoin
Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with MS.
USPTO list of patent term extensions
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.
Demyelination and Remyelination: From Mechanism to Therapy
The Role of the Gut Microbiome on Multiple Sclerosis Risk and Progression
Glatiramer promotes oligodendroglial cell maturation in a cuprizone-induced demyelination model.
The Oxford English Corpus: Facts about the language, The Story of Dictionaries
Episode 57 with Dr. Timothy Vollmer, on the early phase 3 ocrelizumab results and implications
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Episode 43 with Dr. May Han on following patients through the course of their disease
Primary progressive multiple sclerosis-why we are failing.
American Academy of Neurology Fall Conference 2014
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
Risk alleles for multiple sclerosis identified by a genomewide study.
Petite but Potent
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Pages